No. of Pages: 150 | Report Code: BMIRE00026302 | Category: Life Sciences
MEA 人乳头瘤病毒 (HPV) 疫苗市场预计将从 2022 年的 8291 万美元增长到 100.86 美元到 2028 年将达到 100 万；预计 2022 年至 2028 年复合年增长率为 3.3%。
医疗保健组织已经开发并采用了多种预防和消除 HPV 感染的策略。 2020年8月，世界卫生大会通过了消除宫颈癌战略。根据该战略，为了消除宫颈癌，该地区所有国家的宫颈癌发病率必须达到并保持在每 10 万名女性 4 例以下。为了降低宫颈癌的发病率，各国应重点关注宫颈癌的疫苗接种、筛查和治疗。 2016年，Gavi理事会启动了HPV疫苗计划。这使得各国能够在该计划的第一年扩大为 9 岁至 14 岁女孩接种疫苗的规模。通过这项新战略，Gavi 的目标是到 2020 年保护约 4000 万女孩免受宫颈癌的侵害，从而避免约 90 万人死亡。许多国家接受了全球免疫联盟的支持，并将HPV疫苗纳入国家免疫规划。宫颈癌负担最高的国家启动了Gavi HPV疫苗计划。所有这些举措都极大地促进了整个地区的 HPV 疫苗市场。
凭借新功能和技术，供应商可以吸引新客户并扩大他们在新兴市场的足迹。这一因素可能会推动MEA 人乳头瘤病毒 (HPV) 疫苗市场。 MEA 人乳头瘤病毒 (HPV) 疫苗市场预计在预测期内将以良好的复合年增长率增长。
MEA 人乳头瘤病毒 ( HPV）疫苗市场收入及预测至2028年（百万美元）
MEA 人乳头瘤病毒 (HPV) 疫苗市场细分
MEA 人乳头瘤病毒 (HPV) 疫苗市场根据类型、剂量、年龄、应用、最终用户和国家进行细分。根据类型，MEA人乳头瘤病毒（HPV）疫苗市场分为9价HPV疫苗、四价HPV疫苗和二价HPV疫苗。四价 HPV 疫苗在 2022 年占据市场主导地位。根据剂量，MEA 人乳头瘤病毒 (HPV) 疫苗市场分为 2 剂量和 3 剂量。 2022 年，2 剂量细分市场占据主导地位。 根据年龄，MEA 人乳头瘤病毒 (HPV) 疫苗市场分为 9 至 14 岁和 15 至 45 岁。 2022 年，9 至 14 岁细分市场占据主导地位。根据应用情况，MEA 人乳头瘤病毒 (HPV) 疫苗市场分为 HPV 相关癌症和生殖器疣。 HPV 相关癌症细分市场在 2022 年占据主导地位。根据最终用户，MEA 人乳头瘤病毒 (HPV) 疫苗市场分为医生办公室、社区卫生诊所、学校卫生中心、卫生部门、医院等。医院细分市场在 2022 年占据主导地位。根据国家/地区，MEA 人乳头瘤病毒 (HPV) 疫苗市场分为沙特阿拉伯、南非、阿联酋、伊朗、土耳其、科威特、巴林、埃及和 MEA 的其他地区。沙特阿拉伯将在 2022 年占据市场主导地位。
葛兰素史克公司；伊诺维奥制药公司；默克公司有限公司； R-Pharm；赛诺菲；印度血清研究所列兵。有限公司；和沃森生物科技有限公司是 MEA 人乳头瘤病毒 (HPV) 疫苗市场的领先公司。
Strategic insights for Middle East & Africa Human Papillomavirus (HPV) Vaccine involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.
| Report Attribute | Details |
|---|---|
| Market size in 2022 | US$ 82.91 Million |
| Market Size by 2028 | US$ 100.86 Million |
| Global CAGR (2022 - 2028) | 3.3% |
| Historical Data | 2020-2021 |
| Forecast period | 2023-2028 |
| Segments Covered |
By 类型
|
| Regions and Countries Covered | 中东和非洲
|
| Market leaders and key company profiles |
The regional scope of Middle East & Africa Human Papillomavirus (HPV) Vaccine refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.
The Middle East & Africa Human Papillomavirus (HPV) Vaccine Market is valued at US$ 82.91 Million in 2022, it is projected to reach US$ 100.86 Million by 2028.
As per our report Middle East & Africa Human Papillomavirus (HPV) Vaccine Market, the market size is valued at US$ 82.91 Million in 2022, projecting it to reach US$ 100.86 Million by 2028. This translates to a CAGR of approximately 3.3% during the forecast period.
The Middle East & Africa Human Papillomavirus (HPV) Vaccine Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Middle East & Africa Human Papillomavirus (HPV) Vaccine Market report:
The Middle East & Africa Human Papillomavirus (HPV) Vaccine Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The Middle East & Africa Human Papillomavirus (HPV) Vaccine Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the Middle East & Africa Human Papillomavirus (HPV) Vaccine Market value chain can benefit from the information contained in a comprehensive market report.
Office No. 1011, First floor, Farena Corporate Park, Magarpatta-Mundhwa road, Pune - 411028, Maharashtra, India
US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For Middle East & Africa Human Papillomavirus (HPV) Vaccine Market
